Peer Review History
| Original SubmissionJuly 9, 2023 |
|---|
|
PONE-D-23-19499Barriers to implementing Contingency management at a methadone treatment clinic. A qualitative study at a tertiary Hospital in Tanzania.PLOS ONE Dear Dr. Lawala, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 17 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hamidreza Karimi-Sari Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information. 3. In this instance it seems there may be acceptable restrictions in place that prevent the public sharing of your minimal data. However, in line with our goal of ensuring long-term data availability to all interested researchers, PLOS’ Data Policy states that authors cannot be the sole named individuals responsible for ensuring data access (http://journals.plos.org/plosone/s/data-availability#loc-acceptable-data-sharing-methods). Data requests to a non-author institutional point of contact, such as a data access or ethics committee, helps guarantee long term stability and availability of data. Providing interested researchers with a durable point of contact ensures data will be accessible even if an author changes email addresses, institutions, or becomes unavailable to answer requests. Before we proceed with your manuscript, please also provide non-author contact information (phone/email/hyperlink) for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If no institutional body is available to respond to requests for your minimal data, please consider if there any institutional representatives who did not collaborate in the study, and are not listed as authors on the manuscript, who would be able to hold the data and respond to external requests for data access? If so, please provide their contact information (i.e., email address). Please also provide details on how you will ensure persistent or long-term data storage and availability. 4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This manuscript explores barriers to implementing contingency management in a hospital methadone treatment program in Tanzania. This is a generally well-written paper and a very important topic in light of the global opioid crisis. While most comments are minor, one major limitation may be the lack of opinions from methadone treatment participant clients as well as the inclusion of one treatment client in the focus group among program staff and providers. This study would have been much stronger and more valid if either the clients were not included at all or if more clients were included and were offered participation in their own focus group. Other comments: Abstract 1. Does “methadone user” means individuals who are being treated at the methadone clinic? This should probably be “methadone treatment client” or something similar. Methadone user seems like someone who uses methadone illicitly. Background 1. Maybe replace “mental” with “behavioral” in “mental health disorders” (first paragraph) as it is a bit less stigmatizing. 2. Please update some of the refs in paragraph one. For instance, refs 1, 5, and 6 are outdated. 3. Line 59, second paragraph: Contingency management is recommended by who? 4. The introduction needs a clearer discussion of how contingency management is used in opioid treatment (second paragraph of background). Please add from the literature what behaviors may be reinforced through CM as well as examples of the incentives. For instance, monetary, gift cards, and prizes may be offered, but there is very little mention of that in the manuscripts. This would help support the financial barrier finding cited in the manuscript. Also please add some examples of outcomes that have improved from the use of contingency management in methadone treatment from the literature. Some more recent studies would also be important to add. 5. Also in paragraph 2, the citation 7 (“Implementation support for contingency management: preferences of opioid treatment program leaders and staff” may not be the most appropriate reference to support the statement that CM improves substance use outcomes, as this is a qualitative study exploring OTP staff preferences. 6. First line of second paragraph: Instead of saying no references exist, it may be better to say that the literature is sparse or something similar. Methods 1. Were participants paid for study participation? Also please mention if consent was obtained. 2. Were participants from the focus group different than the participants completing IDIs? 3. Why was one methadone treatment client included in the focus group with the providers? If there were not enough treatment clients to participate in the focus group, that client probably should not have been included. First, the power structure where a patient from a stigmatized group (substance user) sits in the same focus group as hospital providers (who may be directly or indirectly responsible for treating these patients) may create a situation where the client or providers may not feel as though they can provide honest feedback (as mentioned in the manuscript, there are trust issues). Additionally, questions asked of patients regarding certain interventions that may be implemented in a program would be very different than those asked of staff and providers. Having one client in with a group of providers may contaminate feedback on provider/administration barriers. This should be included as a limitation. 4. More information should be added on how interview guides were developed. Related to comment 3, above, where questions different for staff and clients? Results 1. I am not sure that figure 1 adds anything to the manuscript. 2. Page 7, line 165: the word “if” may be missing from “in a structured way it could improve…” 3. Page 10, line 248: I believe this should be “latter”, not “ladder” barrier. 4. There are several pages where “.” (periods) and other punctuation are missing (many examples on page 10). The authors should carefully examine the manuscript and edit where needed. 5. Page 10, line 242: “fair” should be “fare” (for transport). 6. The word “motivating” is used throughout (e.g., “motivating” clients). It may be more appropriate to use the word “incentivizing” in most places (e.g., page 10, line 251, “motivating clients is not part of the routine practice.”). 7. Page 10, line 253: where it says “reported presented”: it seems like one of these words should be deleted. Discussion 1. The authors have written a strong discussion section that includes not only a summary of the barriers found during the study, but also potential solutions from the literature. 2. Page 11, line 276: “awareness” maybe should be “lack of awareness”? 3. Page 11, line 278: “motivate” (or similar) may be a better word than “sharpen”. 4. Page 11, line 281: perhaps change “not using drugs other than methadone” to “not using substances other than prescribed methadone”. 5. Page 11, lines 283-284: “after target behaviors performed” is written twice. Is this an error? 6. Page 11, line 286: What is meant by “reducing defaulting” in this context? 7. Page 11, line 289: What is meant by “in monthly or quarterly order”? 8. Page 12, line 305: What are the “additional opioids” that are mentioned as medication costs? 9. Page 12, line 314: that healthcare workers felt they deserved incentives for providing CM is a finding that was not mentioned in the Results section. It should be added there. 10. Page 13 line 330: The sentence that begins “The role of community approach…” and the next two sentences are unclear/awkward as written. Please revise this section and clarify the information that is being communicated. For example, what are the authors meaning by “community-facility linkage”? Tables 1. Table 2: It seems as though many of the quotes included in the table are the same quotes from the manuscript. It would be good if the authors could add more new quotes to support the themes. 2. Similar to comment 1, it is hard to tell how much representation there is among participants whose quotes are listed. For instance, the table is dominated by quotes from 34 y.o. male HCW and 28 y.o. female HCW, as well as some other examples of this. 3. Page 24, 3rd quote: transport “fair” should be “fare”. 4. Table 2: The first quote listed under theme 2 (financing) is included under the theme “trust” in the manuscript. 5. Page 26, “motivation of health workers” is not listed as a theme in the manuscript. It is listed as “workload” in the MS. 6. Page 26: I do not see anything in the MS Results about compensating health workers’ time or health workers should be given incentives to implement CM. 7. Page 26, first quote: This quote seems incomplete (ends with “or”). 8. Page 26, second quote: identifying the quote as being from someone who is an administrator, 45, male may lead to issues with confidentiality/privacy as it may be identifiable. 9. Page 26: Under client behaviors, what is “supervising agreed criteria”? Also, “time needed for services”, “motivation for service providers”, and “time constraints” do not seem to fit under this theme and were not discussed in the manuscript. Reviewer #2: Thank you for your invitation to review this qualitative study that used a CFIR framework to explore the implementation barriers related to contingency management for people who use drugs in a tertiary hospital in Tanzania. The paper identified 6 main themes as barriers to implementing contingency management in the Opioid Treatment Program including 1) awareness and knowledge; 2) Financial barriers to implementation; 3)Trust; 4)Workload; 5)Client behaviors; and 6) Clinic culture Overall, the manuscript is informative and would potentially add to existing knowledge regarding the barriers to implementing contingency management in other developed countries. However, I think the paper would benefit from language editing (For example, I noticed the authors repeatedly use "substance abuse" instead of "substance use" or places with minor grammar/typographical errors). ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-19499R1Barriers to implementing Contingency management at a methadone treatment clinic. A qualitative study at a tertiary Hospital in Tanzania.PLOS ONE Dear Dr. Lawala, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 07 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hamidreza Karimi-Sari Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: PONE-D-23-19499 Barriers to implementing Contingency management at a methadone treatment clinic. A qualitative study at a tertiary Hospital in Tanzania This manuscript explores barriers to implementing contingency management in a hospital methadone treatment program in Tanzania. The manuscript is greatly improved with the revisions. Some issues remain: Abstract 1. “…for methadone use” would probably be better as “for methadone treatment clients.” 2. In conclusion, “to the s identified”, assuming this should be to the barriers identified? Word missing with just an “s”. Background 1. Line 54: Word missing, should this be “…in voucher-based settings are awarded points…”? “Are” is missing. 2. Paragraphs 2 and 3 could be combined. 3. Line 69: does this reference (Petry, 2011) discuss the lack of literature on contingency management in Tanzanian settings? If not just delete it. Methods 1. Were participants paid for study participation? Also please mention if consent was obtained. These important things were not added to the revised manuscript. 2. The authors mention in their comments that the one methadone treatment client included in the focus group with the providers was a leader. This status should be mentioned in the manuscript text. Results 1. I think in several places at the beginning of the quotes, words of expression such as “aah” and “ooh” and “Eeeheee” could be deleted. 2. There are still several places where “.” (periods) and other punctuation are missing. The authors should carefully examine the manuscript and edit where needed. This was not corrected in the revision. 3. Page 7, quote beginning on line 161: This quote does not support how lack of knowledge hindered leaders’ ability to plan or set priorities. Please either change the quote or add text that shows how the quote supports this sentence. 4. Page 7, is there a quote to support the sentence “Participants welcomed the idea of providing the incentives…”? 5. Line 176: Here, and many places, there are some stray letters, in this case the letter “s”. Not sure if this is an issue with the manuscript upload? In any case, the authors need to carefully review the MS for random issues such as these as well as punctuation errors and typos. More examples on page 9 lines 227-233. 6. Page 10, line 246: word missing? Should this be “attend to clients” instead of “attend clients”? 7. The theme of “methadone client’s behaviors” creating barriers to contingency management is not supported by the quotes. The first quote just discusses the behaviors but is not at all connected to their thoughts on how this is a barrier to CM. The second quote is more to do with the clinic budget and capabilities than clients. Either add in supporting quotes or delete this section/theme. Also, the sentence beginning “The latter barrier…” seems to not connect to the rest of the section. Discussion 1. Page 12, line 296: now says “Implementing contingency management to sharpen strengthen.” Please fix. 2. Page 13, line 335: This reference is 18 years old and so may not apply here. You could either update the reference or just delete the second part of the sentence (not needed). 3. Page 13, lines 337-340. This is quite confusing as written. It is not clear what the authors are trying to say here. Sentences/language needs to be modified, and authors may need to expand. 4. Page 13, line 346: What is meant by “attend the culture”? 5. The entire paragraph from lines 341-353 needs to be re-read by someone with English as a first language. There are many things that may have gotten lost in translation here (see #4, above, as an example) as well as many missing words. For instance, “in Tanzanian setting” should be “in the Tanzanian setting” as one example. Tables 1. Table 2: Many of the quotes included in the table are the same quotes from the manuscript. The authors should have different quotes in the table—we have already seen the ones that are listed in the MS. There should be several quotes to support the themes. This was not modified in the revision. 2. Please fix the spacing between quotes in the table. It is difficult to see the quotes separately. 3. Page 27: Under client behaviors, “time needed for services”, “incentives for service providers”, and “time constraints” do not seem to fit under this theme and were not discussed in the manuscript. Actually, only “difficult clients” was discussed in the MS, nothing else that is in this section of the table was in the MS. And, again, most of these quotes do not support the theme of clients’ behaviors as barriers to contingency management. For example, the first quote just discusses that clients may not behave well, but it seems as though that is already and issue and this is not tied into the addition of contingency management. The second quote is a facilitator to implementing CM, it does not mention in any way the poor behaviors of clients as a barrier to implementing CM. Either the theme “client behaviors” needs to be deleted, or quotes that actually support this theme need to be added. 4. In this same theme in the table, what is “wearing sanders”? 5. Under “culture”, why is “suspicion that there will be favoritism” here? It is not in the MS under this theme. 6. The authors need to carefully inspect the tables to make sure that the themes in the tables are expressed the same way as they are in the MS and that the quotes support this. Overall Before publishing, the authors need to: 1) Carefully re-read the manuscript and look for grammar and punctuation issues/errors, language and spelling errors, stray letters, etc. The manuscript does not read at all like a final manuscript as is. It reads like a draft. 2) Have someone read through the manuscript whose first language is English, as there are some phrases that are not clearly translated and some sentences that read awkwardly. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Barriers to implementing Contingency management at a methadone treatment clinic. A qualitative study at a tertiary Hospital in Tanzania. PONE-D-23-19499R2 Dear Dr. Lawala, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hamidreza Karimi-Sari Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-23-19499R2 PLOS ONE Dear Dr. Lawala, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Hamidreza Karimi-Sari Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .